Biologic treatments show promise in providing clinical solutions to a variety of diseases. BBCR can assist with the development of a targeted strategy to meet your study needs.

BBCR’s team has experience in biologics for rare diseases including rare cancers and precision medicine and can help develop a targeted strategy including studies with fewer patients to control safety issues.

Services include:

• Indications analysis and prioritization
• Strategic drug assessment
• Clinical study design and protocol
• Biomarker strategy
• Early Clinical Development
• FDA meeting and submission
• Pre-ND integrated development plan
• CRO and project management
• Study remediation and rescue

Contact Us To Learn More

Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.

"*" indicates required fields

NAME:*

EMAIL:*

PHONE NUMBER:

COMMENTS:*

CAPTCHA

Comments

This field is for validation purposes and should be left unchanged.